These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 26397944

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. Utility of a precursor-to-product ratio in the evaluation of presumptive positives in newborn screening of congenital adrenal hyperplasia.
    Tieh PY, Yee JK, Hicks RA, Mao CS, Lee WN.
    J Perinatol; 2017 Mar; 37(3):283-287. PubMed ID: 27929529
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.
    Hayashi GY, Carvalho DF, de Miranda MC, Faure C, Vallejos C, Brito VN, Rodrigues AS, Madureira G, Mendonca BB, Bachega TA.
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):480-487. PubMed ID: 27978607
    [Abstract] [Full Text] [Related]

  • 69. A rapid UPLC-MS/MS method for simultaneous separation of 48 acylcarnitines in dried blood spots and plasma useful as a second-tier test for expanded newborn screening.
    Gucciardi A, Pirillo P, Di Gangi IM, Naturale M, Giordano G.
    Anal Bioanal Chem; 2012 Aug; 404(3):741-51. PubMed ID: 22766757
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. Evaluation of a Two-Tier Screening Pathway for Congenital Adrenal Hyperplasia in the New South Wales Newborn Screening Programme.
    Lai F, Srinivasan S, Wiley V.
    Int J Neonatal Screen; 2020 Sep; 6(3):63. PubMed ID: 33117905
    [Abstract] [Full Text] [Related]

  • 74. A three-year follow-up of congenital adrenal hyperplasia newborn screening.
    Pezzuti IL, Barra CB, Mantovani RM, Januário JN, Silva IN.
    J Pediatr (Rio J); 2014 Sep; 90(3):300-7. PubMed ID: 24560529
    [Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. Automated high-capacity on-line extraction and bioanalysis of dried blood spot samples using liquid chromatography/high-resolution accurate mass spectrometry.
    Oliveira RV, Henion J, Wickremsinhe ER.
    Rapid Commun Mass Spectrom; 2014 Nov 30; 28(22):2415-26. PubMed ID: 25303470
    [Abstract] [Full Text] [Related]

  • 78. Development of tandem mass spectrometry-based creatinine measurement using dried blood spot for newborn mass screening.
    Nakano M, Uemura O, Honda M, Ito T, Nakajima Y, Saitoh S.
    Pediatr Res; 2017 Aug 30; 82(2):237-243. PubMed ID: 28422942
    [Abstract] [Full Text] [Related]

  • 79. Application of Principal Component Analysis to Newborn Screening for Congenital Adrenal Hyperplasia.
    Lasarev MR, Bialk ER, Allen DB, Held PK.
    J Clin Endocrinol Metab; 2020 Aug 01; 105(8):. PubMed ID: 32525982
    [Abstract] [Full Text] [Related]

  • 80. Improving neonatal screening for congenital adrenal hyperplasia.
    Speiser PW.
    J Clin Endocrinol Metab; 2004 Aug 01; 89(8):3685-6. PubMed ID: 15292288
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.